HIGLOBIN

Welcome to the Brand page for “HIGLOBIN”, which is offered here for Blood, blood derivatives, pharmaceuticals derived from recombinant dna technology all for medical use in the prevention and treatment of blood disorders; intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy;.

Its status is currently believed to be active. Its class is unavailable. “HIGLOBIN” is believed to be currently owned by “CSL BEHRING AG”.

Owner:
CSL BEHRING AG
Owner Details
Description:
Blood, blood derivatives, pharmaceuticals derived from recombinant DNA Technology all for medical use in the prevention and treatment of blood disorders; intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy;
Categories: BLOOD